Sign in to view content

One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa

Benjamin Bakall, MD, PhD

Video
Published 2024

Related

Stem Cell Therapy
Mark S. Humayun, MD, PhD
Updates from the Field
2017
Is the Choroid Driving the Development of Cystoid Macular Edema in Eyes With Retinitis Pigmentosa?
David Sarraf, MD
Annual Meeting Talks
2019
Safety and Efficacy of Intravitreal Optogenetic Gene Therapy for Advanced Retinitis Pigmentosa
Sai H Chavala, MD
On Demand Cases, Courses, and Papers
2021

Category: Hereditary Retinal Disease & Genetics

See more